Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GUAIFENESIN vs GUSELKUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GUAIFENESIN vs GUSELKUMAB: Safety Overview

Metric GUAIFENESIN GUSELKUMAB
Total FAERS Reports 8,042 27,987
Deaths Reported 158 364
Death Rate 2.0% 1.3%
Hospitalizations 371 2,031
Average Patient Age 63.4 yrs 52.6 yrs
% Female Patients 64.3% 57.6%
FDA Approval Date Aug 21, 2023 N/A
Manufacturer Ohm Laboratories, Inc. Janssen Biotech, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status OTC Prescription